Telangana High Court: Barring People with over Two Children From Polls Violates No Fundamental Right  ||  Del HC Clarifies That Breach of Promise to Marry is Not The Same as False Promise Amounting To Rape  ||  Delhi High Court Rules Law Students Cannot be Barred From Exams For Not Meeting Minimum Attendance  ||  Delhi HC: Only a Sessions Court, Not an Ilaqa Magistrate, Can Order Further Probe After Committal  ||  Allahabad High Court: Protecting Homebuyers’ Interests is Paramount in Real Estate Insolvency  ||  Allahabad HC: Police Can Freeze Accounts on Suspicion; Affected Party May Seek Magistrate’s Relief  ||  NCLAT: Claimants Must Prove Asset Ownership; Liquidator Need Not Establish Title of Assets in Custody  ||  NCLAT: Director’s Resignation Doesn’t Release Personal Guarantor from Continuing Guarantee Liability  ||  NCLAT: Delay Condonable When Composite Appeal Filed in Time is Refiled after Registry’s Objection  ||  Supreme Court: Upper Floors Can be Converted for Commercial Use Only after Paying Conversion Charges    

DGFT Changes Export Policy of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients - (15 Jun 2021)

CIVIL

Director-General of Foreign Trade (DGFT) has notified the changes in the Export policy of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients from ‘Prohibited’ to ‘Restricted’. Further, export of Injection Remdesivir and Remdesivir API against Advance Authorizations issued under Chapter 4 of Foreign Trade Policy/Handbook of Procedures shall not require separate export authorization or permission.

Tags : DIRECTOR-GENERAL OF FOREIGN TRADE   EXPORT POLICY OF INJECTION REMDESIVIR AND REMDESIVIR ACTIVE PHARMACEUTICAL INGREDIENTS  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved